References: Hair growth and hair loss
Hepatol Res. 2002 Jan;22(1):1-12.
A multicenter, randomized, controlled clinical trial of interferon alfacon-1 in comparison with lymphoblastoid interferon-alpha in patients with high-titer chronic hepatitis C virus infection.
Suzuki H, Tango T.
, Yamanashi-ken, Japan
This multicenter, randomized, controlled study evaluated the efficacy and safety of interferon alfacon-1 (r-IFN-alphacon1) compared with lymphoblastoid interferon-alpha (IFN-alphan1) in patients with high-titer chronic hepatitis C virus (HCV) infection. Two hundred and seven patients were randomized to receive either 18 MIU (&mgr;g) r-IFN-alphacon1 or 9 MIU IFN-alphan1 daily for 2 weeks, followed by the administration of the study drugs three times weekly for 22 weeks. The primary endpoint was sustained virological response defined as the inability to detect serum HCV RNA at the end of the 24 week post-treatment observation period. In the intention-to-treat analysis, r-IFN-alphacon1 produced a slightly but not significantly higher proportion of sustained virological response than IFN-alphan1 (26.3 vs. 20.7% P=0.392). In patients with high baseline titer and genotype 1b, the proportion of sustained virological response was significantly higher in the r-IFN-alphacon1 cohort, than the IFN-alphan1 cohort (16.7 vs. 3.3%, P=0.017). The adverse events commonly reported were flu-like symptoms, anorexia, insomnia, and alopecia. Types and frequencies of the adverse events were similar in the two cohorts. The results of this study show that r-IFN-alphacon1 is an effective and tolerable therapy in patients with chronic HCV with high viral titer. The results also indicate that 18 MIU r-IFN-alphacon1 is superior in efficacy without additional toxicity to 9 MIU IFN-alphan1 in high-titer chronic HCV patients, particularly with genotype 1b.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11804828&dopt=Abstract [PubMed - as supplied by publisher]
J Am Acad Dermatol. 2002 Feb;46(2 Suppl Understanding):S120-4.
Tinea capitis: focus on African American women.
Silverberg NB, Weinberg JM, DeLeo VA.
Skin of Color Center, Department of Dermatology, St. Luke's-Roosevelt Hospital, New York, NY 10025, USA.
Tinea capitis is a common cutaneous fungal infection in US school children, but adults may be carriers of tinea pathogens in the scalp. However, few cases of actual tinea capitis in adults have been reported in the literature. A retrospective analysis of all adult patients with positive scalp fungal cultures from June 1997 to March 2000 were reviewed. Seventy-nine cases of tinea capitis were identified. Nine (11.4%) were adults, 7 of whom were African American women, who were an average of 46 years old (range, 25 to 64 years). Three of these patients had prior exposure to a child with tinea capitis. These results suggest that tinea capitis affects adult African Americans, particularly women. Widespread scalp culture is indicated for papulosquamous disease and alopecia in this segment of the population.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11807474&dopt=Abstract
J Perianesth Nurs. 2000 Oct;15(5):355-6.
Locks of love.
Sandlin D.
Pre-Operative Holding Unit of Southern Hills Medical Center, Nashville, TN, USA.
Locks of Love is a nonprofit organization that provides custom hairpieces to financially disadvantaged children under age 18 across the United States who are suffering from long-term medical hair loss. This article will provide information to those readers who wish to cut their long hair and donate it to a needy child or to those who may simply be interested in learning more about this organization.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11811339&dopt=Abstract
Natural Herbal Supplements ||
Hair Million herbal formula for hair loss and hair growth ||
Hair growth research references ||
Online Pharmacy : discount prescription medication ||